Bhavesh Ashar Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Bhavesh Ashar is Chief Commercial Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 63,069 shares of SWTX, which is worth approximately $2.37 Million. The most recent transaction as insider was on Jan 10, 2025, when has been sold 17,323 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.1K

11.96% 3M change

4.74% 12M change

Total Value Held $2.37 Million

Bhavesh Ashar Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2025	BUY Grant, award, or other acquisition	-	17,323 Added 21.55%	63,069 Common Stock
Jan 06 2025	SELL Payment of exercise price or tax liability	$88,756 $38.86 p/Share	2,284 Reduced 4.76%	45,746 Common Stock
Jan 05 2025	SELL Payment of exercise price or tax liability	$146,076 $38.19 p/Share	3,825 Reduced 7.38%	48,030 Common Stock
Jan 04 2025	SELL Payment of exercise price or tax liability	$170,900 $38.19 p/Share	4,475 Reduced 7.94%	51,855 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$86,858 $47.62 p/Share	1,824 Reduced 3.14%	56,330 Common Stock
Feb 05 2024	SELL Open market or private sale	$238,412 $49.32 p/Share	4,834 Reduced 7.67%	58,154 Common Stock
Feb 02 2024	SELL Open market or private sale	$145,344 $45.11 p/Share	3,222 Reduced 4.87%	62,988 Common Stock
Jan 08 2024	SELL Payment of exercise price or tax liability	$60,176 $41.53 p/Share	1,449 Reduced 2.14%	66,210 Common Stock
Jan 05 2024	SELL Payment of exercise price or tax liability	$95,165 $37.96 p/Share	2,507 Reduced 3.57%	67,659 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	26,445 Added 27.37%	70,166 Common Stock
Apr 03 2023	SELL Payment of exercise price or tax liability	$34,718 $25.25 p/Share	1,375 Reduced 3.05%	43,721 Common Stock
Jan 06 2023	SELL Payment of exercise price or tax liability	$45,820 $27.52 p/Share	1,665 Reduced 3.56%	45,096 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	22,663 Added 32.64%	46,761 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$83,302 $56.9 p/Share	1,464 Reduced 5.73%	24,098 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	13,062 Added 33.82%	25,562 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	12,500 Added 50.0%	12,500 Common Stock

Bhavesh Ashar

Chief Commercial Officer

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX

Account